Corona Virus Net is the web resource for anyone interested in Coronaviruses. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (COVID-19) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and humans. Common signs of infection include respiratory symptoms, fever, cough, and shortness of breath. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing. Also avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.

A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO on 31 December 2019. The outbreak of COVID-19 was declared a Public Health Emergency of International Concern on 30 January 2020 by the WHO. As of March 11th, the WHO declared the rapidly spreading coronavirus outbreak a pandemic, acknowledging that the virus will likely spread to all countries in the world.

The objectives of Corona Virus Net are to be the public and professional information resource for coronaviruses and to serve as a network in the exchange of information and news related to coronaviruses. What do you know about the novel Coronavirus that is causing a health emergency?

• Japan To Lift All Coronavirus Emergency Steps Nationwide - NPR
  Tue, 28 Sep 2021 09:28 GMT
• Indiana coronavirus updates: Elementary school-aged children could get Pfizer's COVID-19 vaccine by late October - WTHR
  Tue, 28 Sep 2021 07:34 GMT
• COVID by the Numbers: Coronavirus Metrics in Each of Illinois' 11 Health Care Regions - NBC Chicago
  Tue, 28 Sep 2021 01:14 GMT
• Governor Lamont Provides Update on Connecticut's Coronavirus Response Efforts - CT.gov
  Mon, 27 Sep 2021 21:25 GMT
• Daily pace of new Covid-19 vaccinations is the lowest since the CDC started tracking in mid-January - CNN
  Mon, 27 Sep 2021 23:36 GMT
• Coronavirus Briefing: What Happened Today - The New York Times
  Mon, 27 Sep 2021 21:27 GMT
• Coronavirus in Georgia | COVID case, death, and hospitalization data Sept. 27 - 11Alive.com WXIA
  Mon, 27 Sep 2021 20:28 GMT
• Why Do Some People Develop Severe COVID Symptoms From Novel Coronavirus? - SciTechDaily
  Tue, 28 Sep 2021 05:07 GMT
• Covid-19 live updates: Pace of U.S. vaccinations slows in September - The Washington Post
  Tue, 28 Sep 2021 09:56 GMT
• Indiana coronavirus updates for Monday, Sept. 27, 2021 - WTHR
  Mon, 27 Sep 2021 07:59 GMT
• Dallas County reports 17 new COVID-19 deaths, 1,074 coronavirus cases - The Dallas Morning News
  Mon, 27 Sep 2021 23:52 GMT
• Coronavirus in Colorado: COVID-19 updates for Sept. 27-Oct. 3, 2021 - The Denver Channel
  Mon, 27 Sep 2021 18:55 GMT
• COVID-19: What you need to know about the coronavirus pandemic on 27 September - World Economic Forum
  Mon, 27 Sep 2021 11:36 GMT
• Hawaii sees 255 new coronavirus cases, bringing statewide total to 78,404 - Honolulu Star-Advertiser
  Mon, 27 Sep 2021 19:18 GMT
• China reports 31 new coronavirus cases for Sept 27 vs 35 a day earlier - Yahoo Finance
  Tue, 28 Sep 2021 01:01 GMT

• PRO/AH/EDR> COVID-19 update (323): Pfizer vaccine in children, vaccine diplomacy, WHO
  Mon, 20 Sep 2021 21:44:10 -0400
  COVID-19 -- Worldwide/Unknown
  A lower dose of the Pfizer-BioNTech coronavirus vaccine -- one-3rd the amount given to adults and teens -- is safe and triggered a robust immune response in children as young as 5 years old, the drug companies announced in a news release Monday morning.
  The finding, eagerly anticipated by many parents and pediatricians, is a crucial step toward the 2-shot coronavirus vaccine regimen becoming available for younger school-aged children, perhaps close to Halloween.
  The companies still must

• Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination Mon, 27 Sep 2021 06:00:00 -0400
  BACKGROUND: To optimise the use of available SARS-CoV-2 vaccines, some advocate delaying second vaccination for individuals infected within six months. We studied whether post-vaccination immune response is equally potent in individuals infected over six months prior to vaccination.
• High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic Mon, 27 Sep 2021 06:00:00 -0400
  Cryopreservation and re-transplantation of ovarian tissue after anticancer treatment is important medical technology. Today, during a pandemic, the risk of contamination of transplanted cells with SARS-CoV-2 virus is extremely high. Data about cryo-resistance (virulence and/or infectivity) of SARS-CoV-2 are limited. Analysis and systematization of literature data allow us to draw the following conclusions: 1) The cytoplasmic membrane of somatic cell, like envelope of corona viruses, consists of...
• Disinfection and Electrostatic Recovery of N95 Respirators by Corona Discharge for Safe Reuse Mon, 27 Sep 2021 06:00:00 -0400
  With the COVID-19 pandemic surging, the demand for masks is challenging, especially in less-developed areas across the world. Billions of used masks are threatening the environment as a new source of plastic pollution. In this paper, corona discharge (CD) was explored as a safe and reliable method for mask reuse to alleviate the situation. CD can disinfect masks and simultaneously restore electrostatic charges to prevent filtration efficiency deterioration. Electric field, ions, and reactive...
• Protein Corona Inhibits Endosomal Escape of Functionalized DNA Nanostructures in Living Cells Mon, 27 Sep 2021 06:00:00 -0400
  DNA nanostructures (DNs) can be designed in a controlled and programmable manner, and these structures are increasingly used in a variety of biomedical applications, such as the delivery of therapeutic agents. When exposed to biological liquids, most nanomaterials become covered by a protein corona, which in turn modulates their cellular uptake and the biological response they elicit. However, the interplay between living cells and designed DNs are still not well established. Namely, there are...
• Frequency and outcomes of gastrointestinal symptoms in patients with Corona Virus Disease-19 Mon, 27 Sep 2021 06:00:00 -0400
  CONCLUSIONS: Screening questions should be expanded to include common GI symptoms in patients with COVID-19. Health care providers should note whether their patient is presenting with diarrhea due to the potential implications on disease severity and outcomes.
• Invasive mechanical ventilation and clinical parameters in COVID19 patient: Can age be a factor? Mon, 27 Sep 2021 06:00:00 -0400
  CONCLUSIONS: The findings of the study indicated that prognosis of COVID19 patients under invasive mechanical ventilation in terms of changes in clinical parameters might not be associated with the age.
• A comprehensive insight on the COVID-19 vaccine candidates Mon, 27 Sep 2021 06:00:00 -0400
  The world is currently facing a pandemic triggered by the novel corona virus (SARS - CoV2), which causes a highly infectious infection that predominantly affects the lungs, resulting in a variety of clinical symptoms some cases may be asymptomatic while others may result in to severe respiratory disorder, if the infection is left unattended it may result in multi-organ failure and eventually death of the patient. The transmission of infection is by droplet and fomites of the infected person. The...
• Repercussions of lockdown on primary health care in India during COVID 19 Mon, 27 Sep 2021 06:00:00 -0400
  Primary health care is a comprehensive care with a wide range of essential services for people living in the rural and hard-to-reach areas. However, the primary healthcare delivery system in India is still in its initial stages and lacks human resources. With the COVID-19 pandemic around the corner, there has been a diversion of resources for controlling corona pandemic leading to undermining availability and accessibility of health services. This article highlights a few case scenarios and the...
• Self-powered ammonia synthesis under ambient conditions via N₂ discharge driven by Tesla turbine triboelectric nanogenerators Mon, 27 Sep 2021 06:00:00 -0400
  Ammonia synthesis using low-power consumption and eco-friendly methods has attracted increasing attention. Here, based on the Tesla turbine triboelectric nanogenerator (TENG), we designed a simple and effective self-powered ammonia synthesis system by N(2) discharge. Under the driving of the simulated waste gas, the Tesla turbine TENG showed high rotation speed and high output. In addition, the performance of two Tesla turbine TENGs with different gas path connections was systematically...
• COVID-19 and its implications for obstetrics and gynecology practice in Africa Mon, 27 Sep 2021 06:00:00 -0400
  Having to cope with corona virus disease 2019 (COVID-19) is likely to create imbalances in health care provision in the obstetrics and gynecology practices in Africa where most countries still battle with high rate of maternal morbidities and mortalities as well as poor or inadequate quality gynecological care. COVID-19 has spread to the continents of the world including all African nations since it was first reported in Wuhan, China in December 2019. Its impact and implications on the...